Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection

Abstract Duck enteritis virus (DEV), duck tembusu virus (DTMUV), and highly pathogenic avian influenza virus (HPAIV) H5N1 are the most important viral pathogens in ducks, as they cause significant economic losses in the duck industry. Development of a novel vaccine simultaneously effective against t...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zhong Zou, Kun Huang, Yanmin Wei, Huanchun Chen, Ziduo Liu, Meilin Jin
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2017
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/68c17360fa634ca7885818d33aa666d2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:68c17360fa634ca7885818d33aa666d2
record_format	dspace
spelling	oai:doaj.org-article:68c17360fa634ca7885818d33aa666d22021-12-02T15:06:05ZConstruction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection10.1038/s41598-017-01554-12045-2322https://doaj.org/article/68c17360fa634ca7885818d33aa666d22017-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01554-1https://doaj.org/toc/2045-2322Abstract Duck enteritis virus (DEV), duck tembusu virus (DTMUV), and highly pathogenic avian influenza virus (HPAIV) H5N1 are the most important viral pathogens in ducks, as they cause significant economic losses in the duck industry. Development of a novel vaccine simultaneously effective against these three viruses is the most economical method for reducing losses. In the present study, by utilizing a clustered regularly interspaced short palindromic repeats (CRISPR)/associated 9 (Cas9)-mediated gene editing strategy, we efficiently generated DEV recombinants (C-KCE-HA/PrM-E) that simultaneously encode the hemagglutinin (HA) gene of HPAIV H5N1 and pre-membrane proteins (PrM), as well as the envelope glycoprotein (E) gene of DTMUV, and its potential as a trivalent vaccine was also evaluated. Ducks immunized with C-KCE-HA/PrM-E enhanced both humoral and cell-mediated immune responses to H5N1 and DTMUV. Importantly, a single-dose of C-KCE-HA/PrM-E conferred solid protection against virulent H5N1, DTMUV, and DEV challenges. In conclusion, these results demonstrated for the first time that the CRISPR/Cas9 system can be applied for modification of the DEV genome rapidly and efficiently, and that recombinant C-KCE-HA/PrM-E can serve as a potential candidate trivalent vaccine to prevent H5N1, DTMUV, and DEV infections in ducks.Zhong ZouKun HuangYanmin WeiHuanchun ChenZiduo LiuMeilin JinNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Zhong Zou Kun Huang Yanmin Wei Huanchun Chen Ziduo Liu Meilin Jin Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection
description	Abstract Duck enteritis virus (DEV), duck tembusu virus (DTMUV), and highly pathogenic avian influenza virus (HPAIV) H5N1 are the most important viral pathogens in ducks, as they cause significant economic losses in the duck industry. Development of a novel vaccine simultaneously effective against these three viruses is the most economical method for reducing losses. In the present study, by utilizing a clustered regularly interspaced short palindromic repeats (CRISPR)/associated 9 (Cas9)-mediated gene editing strategy, we efficiently generated DEV recombinants (C-KCE-HA/PrM-E) that simultaneously encode the hemagglutinin (HA) gene of HPAIV H5N1 and pre-membrane proteins (PrM), as well as the envelope glycoprotein (E) gene of DTMUV, and its potential as a trivalent vaccine was also evaluated. Ducks immunized with C-KCE-HA/PrM-E enhanced both humoral and cell-mediated immune responses to H5N1 and DTMUV. Importantly, a single-dose of C-KCE-HA/PrM-E conferred solid protection against virulent H5N1, DTMUV, and DEV challenges. In conclusion, these results demonstrated for the first time that the CRISPR/Cas9 system can be applied for modification of the DEV genome rapidly and efficiently, and that recombinant C-KCE-HA/PrM-E can serve as a potential candidate trivalent vaccine to prevent H5N1, DTMUV, and DEV infections in ducks.
format	article
author	Zhong Zou Kun Huang Yanmin Wei Huanchun Chen Ziduo Liu Meilin Jin
author_facet	Zhong Zou Kun Huang Yanmin Wei Huanchun Chen Ziduo Liu Meilin Jin
author_sort	Zhong Zou
title	Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection
title_short	Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection
title_full	Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection
title_fullStr	Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection
title_full_unstemmed	Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection
title_sort	construction of a highly efficient crispr/cas9-mediated duck enteritis virus-based vaccine against h5n1 avian influenza virus and duck tembusu virus infection
publisher	Nature Portfolio
publishDate	2017
url	https://doaj.org/article/68c17360fa634ca7885818d33aa666d2
work_keys_str_mv	AT zhongzou constructionofahighlyefficientcrisprcas9mediatedduckenteritisvirusbasedvaccineagainsth5n1avianinfluenzavirusandducktembusuvirusinfection AT kunhuang constructionofahighlyefficientcrisprcas9mediatedduckenteritisvirusbasedvaccineagainsth5n1avianinfluenzavirusandducktembusuvirusinfection AT yanminwei constructionofahighlyefficientcrisprcas9mediatedduckenteritisvirusbasedvaccineagainsth5n1avianinfluenzavirusandducktembusuvirusinfection AT huanchunchen constructionofahighlyefficientcrisprcas9mediatedduckenteritisvirusbasedvaccineagainsth5n1avianinfluenzavirusandducktembusuvirusinfection AT ziduoliu constructionofahighlyefficientcrisprcas9mediatedduckenteritisvirusbasedvaccineagainsth5n1avianinfluenzavirusandducktembusuvirusinfection AT meilinjin constructionofahighlyefficientcrisprcas9mediatedduckenteritisvirusbasedvaccineagainsth5n1avianinfluenzavirusandducktembusuvirusinfection
_version_	1718388587282563072

Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection

Ejemplares similares